[1]温旭涛,杨希立,舒建坤,等.术前血清可溶性ST2水平对心房颤动射频消融术后复发的预测价值研究[J].现代检验医学杂志,2022,37(03):191-197.[doi:10.3969/j.issn.1671-7414.2022.03.040]
　WEN Xu-tao,YANG Xi-li,SHU Jian-kun,et al.Value of Preoperative Serum Soluble ST2 Level in Predicting Recurrence of Atrial Fibrillation after Radiofrequency Ablation[J].Journal of Modern Laboratory Medicine,2022,37(03):191-197.[doi:10.3969/j.issn.1671-7414.2022.03.040]
点击复制

术前血清可溶性ST2水平对心房颤动射频消融术后复发的预测价值研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第37卷
期数:
2022年03期
页码:
191-197
栏目:
检验与临床
出版日期:
2022-05-15

文章信息/Info

Title:
Value of Preoperative Serum Soluble ST2 Level in Predicting Recurrence of Atrial Fibrillation after Radiofrequency Ablation
文章编号:
1671-7414（2022）03-191-07
作者:
温旭涛; 杨希立; 舒建坤; 许兆延; 李炜杰
（佛山市第一人民医院心血管内科，广东佛山 528000）
Author(s):
WEN Xu-tao;  YANG Xi-li;  SHU Jian-kun;  XU Zhao-yan;  LI Wei-jie
（Department of Cardiology，the First People’s Hospital of Foshan, Guangdong Foshan 528000，China）
关键词:
可溶性生长刺激表达基因2 蛋白; 心房颤动; 射频消融术; 反向传播神经网络模型
分类号:
R541.75；R392.11
DOI:
10.3969/j.issn.1671-7414.2022.03.040
文献标志码:
A
摘要:
目的　探究术前可溶性生长刺激表达基因 2（soluble growth stimulation expressed gene 2 ，sST2）蛋白对心房颤动射频消融术后复发的预测价值。方法　选择 2019年 12月～ 2021年 9月于佛山市第一人民医院行射频消融术治疗的心房颤动患者作为研究对象，根据术后复发情况，将患者分为复发组（ 41例）和非复发组（ 79例）。比较两组患者的一般资料、心脏彩超检查指标及血液生化指标，多因素 Logistic回归分析影响患者术后复发的因素；受试者工作特征曲线（ROC）评价术前 sST2对患者术后复发的预测价值并获得最佳临界值，根据临界值将患者分为 sST2低表达组和高表达组， Kaplan-Meier法绘制生存曲线比较两组患者的术后复发情况； Pearson检验分析术前 sST2与其它危险因素的相关性；构建反向传播（ back propagation，BP）神经网络模型，评价其预测效能。结果　左房内径（ left artrial diameter, LAD）增加、血清尿酸（ uric acid, UA）升高、氨基末端脑钠肽前体（ N-terminal pro-brain natriuretic peptide, NT-proBNP）升高、超敏 C反应蛋白（high-sensitivity C-reactive protein, hs-CRP）升高、白介素（interleukin, IL）-6升高、sST2升高是导致心房颤动患者射频消融术后复发的独立危险因素（ OR=3.372，3.728，3.183，3.645，3.473，2.906，均 P＜ 0.05）；sST2预测患者术后复发的 ROC曲线下面积为 0.796（95%CI：0.726～ 0.842，P＜ 0.001），最佳临界值为 151.46 ng/ml， sST2低表达组术后未复发率（ 78.16%）明显高于 sST2高表达组（ 33.33%），差异有统计学意义（ Log-Rank χ2= 21.374，P＜ 0.001）；sST2与 LAD，UA，NT-proBNP，hs-CRP和 IL-6均呈明显正相关（ r=0.732，0.565，0.683，0.501，0.469，均 P＜ 0.05）；BP神经网络模型预测患者术后复发的准确性和有效性较好。结论　术前高水平 sST2与心房颤动患者射频消融术后复发有关，对患者术后复发有一定的预测价值。
Abstract:
Objective　To explore the predictive value of preoperative soluble growth stimulation expressed gene 2 (sST2) protein for recurrence after radiofrequency ablation of atrial fibrillation. Methods　Patients with atrial fibrillation who underwent radiofrequency ablation in the First People’s Hospital of Foshan from December 2019 to September 2021 were selected. According to the postoperative recurrence, the patients were divided into recurrent group (n=41) and non-recurrent group (n=79). The general data, cardiac color Doppler ultrasound examination indexes and blood biochemical indexes were compared between the two groups of patients. Multivariate Logistic regression analysis was used to analyze the factors affecting postoperative recurrence of patients. The receiver operating characteristic (ROC) curve evaluated the predictive value of preoperative sST2 for postoperative recurrence and obtained the best critical value. According to the critical value, the patients were divided into sST2 low expression group and high expression group. Kaplan-Meier method was used to draw survival curve to compare the postoperative recurrence of the two groups of patients. Pearson test analyzed preoperative sST2 and other risks correlation of factors, and constructed a back propagation (BP) neural network model to evaluate its predictive effectiveness. Results　 Increased left atrial diameter (LAD) and all increased serum uric acid (UA), N-terminal pro-brain natriuretic peptide (NTproBNP), high-sensitivity C-reactive protein (hs-CRP), interleukin (IL)-6 and sST2 were independent risk factors for recurrence after radiofrequency ablation in patients with atrial fibrillation (OR=3.372, 3.728, 3.183, 3.645, 3.473, 2.906, all P ＜ 0.05). The area under the ROC curve for sST2 to predict postoperative recurrence in patients was 0.796 (95%CI: 0.726 ～ 0.842, P＜ 0.001), and the best cut-off value was 151.46 ng/ml, the postoperative non-recurrence rate (78.16%) of the sST2 low expression group was significantly higher than that of the sST2 high expression group (33.33%), the difference was statistically significant (Log- Rank χ2=21.374, P ＜ 0.001). sST2 was significantly positively correlated with LAD, UA, NT-proBNP, hs-CRP, and IL-6 (r=0.732, 0.565, 0.683, 0.501, 0.469, all P ＜ 0.05). The BP neural network model had better accuracy and effectiveness in predicting postoperative recurrence. Conclusion　The preoperative high level of sST2 was related to the recurrence of patients with atrial fibrillation after radiofrequency ablation, and has a certain predictive value for patients with postoperative recurrence.

参考文献/References:

[1] MCCABE P J, KUMBAMU A, STUART-MULLEN L, et al. Exploring patients’ values and preferences for initial atrial fibrillation education[J]. The Journal of Cardiovascular Nursing, 2020, 35(5): 445-455.
[2] NG V W S, SIU C W, CHIU P K C , e t a l . Understanding the barriers to using oral anticoagulants among long-term aspirin users with atrial fibrillation - a qualitative study[J]. BMC Health Services Research, 2020, 20(1): 1084.
[3] SLAVENBURG M, VAN DEN BENT J H, BARTEN T, et al. Perceptions and experiences of atrial fibrillation patients on their condition and oral anticoagulant treatment[J]. Cardiology and Therapy, 2020, 9(2): 409- 420.
[4] CHERIAN T S, CALLANS D J. Recurrent atrial fibrillation after radiofrequency ablation: what to expect[J]. Cardiac Electrophysiology Clinics, 2020, 12(2): 187-197.
[5] OSAKA Y, ONO Y, TAO S, et al. Feasibility and safety of uninterrupted apixaban in patients undergoing radiofrequency ablation for atrial fibrillation[J]. Journal of Interventional Cardiac Electrophysiology, 2020, 58(1): 35-41.
[6] UKITA K, EGAMI Y, KAWAMURA A, et al. Clinical impact of very early recurrence of atrial fibrillation after radiofrequency catheter ablation[J]. Journal of Cardiology, 2021, 78(6): 571-576.
[7] 高婉琴, 李小丹, 杨朋康, 等. 血清Galectin-3 和 sST2 水平检测用于保留射血分数心力衰竭的生物标 记物的研究[J]. 现代检验医学杂志, 2019, 34（6）： 54-59． GAO Wanqin, LI Xiaodan, YANG Pengkang, et al. Study on Galectin-2 and sST2 used as biomarker for heart faliure patient with preserved ejection fraction[J]. Journal of Modern Laboratory Medicine, 2019,34(6):54-59.
[8] SAEZ-MALETA R, MERINO-MERINO A, GUNDINMENENDEZ S, et al. sST2 and galectin-3 genotyping in patients with persistent atrial fibrillation[J]. Molecular Biology Reports, 2021, 48(2): 1601-1606.
[9] 黄从新, 张澍, 黄德嘉, 等. 心房颤动: 目前的认识 和治疗建议(2018)[J]. 中华心律失常学杂志, 2018, 22(4):279-346. HUANG Congxin, ZHANG Shu, HUANG Dejia, et al. Current knavledge and management recommendations of atrial fibrillation: 2018[J]. Chinese Journal of Cardiac Arrhythmias, 2018, 22(4):279-346.
[10] ZHANG Weifang, XIONG Youwen, YU Lingling, et al. Meta-analysis of stroke and bleeding risk in patients with various atrial fibrillation patterns receiving oral anticoagulants[J]. The American Journal of Cardiology, 2019, 123(6): 922-928.
[11] PASTORI D, FARCOMENI A, PIGNATELLI P, et al. ABC (atrial fibrillation better care) pathway and healthcare costs in atrial fibrillation: the ATHEROAF study[J]. The American Journal of Medicine, 2019, 132(7): 856-861.
[12] HIRSCHY R, ACKERBAUER K A, PEKSA G D, et al. Metoprolol vs. diltiazem in the acute management of atrial fibrillation in patients with heart failure with reduced ejection fraction[J]. The American Journal of Emergency Medicine, 2019, 37(1): 80-84.
[13] BI Hailian, ZHANG Yunlong, YANG Jie, et al. Inhibition of UCHL1 by LDN-57444 attenuates Ang II-induced atrial fibrillation in mice[J]. Hypertension Research, 2020, 43(3): 168-177.
[14] KOTSIOU O S, JAGIRDAR R M, PAPAZOGLOU E D, et al. Pleural effusion IL-33/sST2 levels and effects of low and high IL-33/sST2 levels on human mesothelial cell adhesion and migration[J]. Inflammation, 2019, 42(6): 2072-2085.
[15] AIMO A, JANUZZI J J, BAYES-GENIS A, et al. Clinical and prognostic significance of sST2 in heart failure: JACC review topic of the week[J]. Journal of the American College of Cardiology, 2019, 74(17): 2193-2203.
[16] RABKIN S W, TANG J K K. The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review[J]. Heart Failure Reviews, 2021, 26(4): 799- 812.
[17] YOU Hongzhao, JIANG Wenxi, JIAO Meng, et al. Association of soluble ST2 serum levels with outcomes in pediatric dilated cardiomyopathy[J]. The Canadian Journal of Cardiology, 2019, 35(6): 727-735.
[18] B U D Z I A N O W S K I J , H I C Z K I E W I C Z J , BURCHARDT P, et al. Predictors of atrial fibrillation early recurrence following cryoballoon ablation of pulmonary veins using statistical assessment and machine learning algorithms[J]. Heart and Vessels, 2019, 34(2): 352-359.
[19] CHEN Suchan, CHUNG Fapo, CHAO T F, et al. A link between bilirubin levels and atrial fibrillation recurrence after catheter ablation[J]. Journal of the Chinese Medical Association, 2019, 82(3): 175-178.
[20] LI Bolin, MA Honglan, GUO Huihui, et al. Pulmonary vein parameters are similar or better predictors than left atrial diameter for paroxysmal atrial fibrillation after cryoablation[J]. Brazilian Journal of Medical and Biological Research, 2019, 52(9): e8446.
[21] 雷志博, 黄改荣. 血清尿酸预测非瓣膜性心房颤动 射频消融术后复发的相关性研究[J]. 中西医结合心 脑血管病杂志, 2020, 18(23):4022-4025. LEI Zhibo, HUANG Gairong. The serum uric acid in predicting the recurrence of nonvalvular atrial fibrillation after radiofrequency ablation [J]. Chinese Journal of Integrative Medicine on Cardio- Cerebrovascular Disease, 2020, 18(23):4022-4025.
[22] KUWABARA M, HISATOME I. Gender difference in the association between uric acid and atrial fibrillation[J]. Circulation Journal, 2018, 83(1): 27-29.
[23] 杜雪莲, 宋坤青, 孟庆红, 等．炎性因子结合NFproBNP 变化水平对心房颤动射频消融术后复发的 预测价值[J]．河北医科大学学报, 2019, 40（7）： 851-854． DU Xuelian, SONG Kunqing, MENG Qinghong, et al. The predictive value of inflammatory factors combined with NF-proBNP changes in the recurrence of atrial fibrillation after radiofrequency ablation[J]. Journal of Hebei Medical University, 2019, 40(7):851-854.
[24] XUAN Zhiming, LIU Boyu, CI Minjun, et al. Hemoptysis secondary to pulmonary vein stenosis after radiofrequency ablation for atrial fibrillation: A case report and literature review[J]. Journal of Interventional Medicine, 2020, 3(2): 98-100.
[25] 陈静, 程庆丰, 陈悦, 等. 糖尿病足患者预后预测相 关模型研究[J]. 重庆医科大学学报, 2020, 45（3）： 394-398． CHEN Jing, CHENG Qingfeng, CHEN Yue, et al. A study of prognostic prediction model for diabetic foot patients [J]. Journal of Chongqing Medical University, 2020, 45(3):394-398.

相似文献/References:

[1]王 勇,张克波.老年心力衰竭患者血清NF-κB，Gal-3 和sST2 水平联合检测与预后评估价值[J].现代检验医学杂志,2022,37(05):148.[doi:10.3969/j.issn.1671-7414.2022.05.029]
　WANG Yong,ZHANG Ke-bo.Prognostic Value of Combined Serum NF-κB, Gal-3 and sST2 Levels in Elderly Patients with Heart Failure[J].Journal of Modern Laboratory Medicine,2022,37(03):148.[doi:10.3969/j.issn.1671-7414.2022.05.029]
[2]李晶晶,刘晓晨,刘恩香,等.心房颤动患者血清miR-29b 和miR-135b 水平表达与心房纤维化程度及射频消融术后复发的相关性研究[J].现代检验医学杂志,2023,38(06):75.[doi:10.3969/j.issn.1671-7414.2023.06.014]
　LI Jingjing,LIU Xiaochen,LIU Enxiang,et al.Correlation between the Expression of miR-29b and miR-135b in Serum of Patients with Atrial Fibrillation and the Degree of Atrial Fibrosis and the Recurrence after Radiofrequency Ablation[J].Journal of Modern Laboratory Medicine,2023,38(03):75.[doi:10.3969/j.issn.1671-7414.2023.06.014]

备注/Memo

备注/Memo:
基金项目：佛山市医学类科技攻关项目（编号：1920001001068）。
作者简介：温旭涛（1979-），男，硕士研究生，副主任医师，研究方向：起搏与电生理，E-mail：wenxutao1980@126.com。
更新日期/Last Update: 1900-01-01